PAF and haematopoiesis: III. Presence and metabolism of platelet-activating factor in human bone marrow.
Platelet-activating factor (PAF) is a phospholipid compound with major immunoregulatory activities. The present study shows that human bone marrow contains 576 +/- 39 pg PAF/ml (n = 35). Bone marrow-derived PAF exhibits the same biophysical and biological properties that synthetic PAF. PAF concentrations in bone marrow are correlated with the granulocyte (r = 0.4, P = 0.02) but not with the lymphocyte (r = 0.24, P = 0.17) and the monocyte (r = 0.12, P = 0.48) counts. In bone marrow PAF is inactivated by a plasma PAF acetylhydrolase activity (48.0 +/- 2.3 nmol/min per ml, n = 34). Experiments with [3H]PAF indicate that human bone marrow cells actively metabolize this potent molecule by the deacetylation-transacylation pathway. Results of this investigation indicate the permanent presence of significant amounts of PAF in bone marrow suggesting its putative involvement in the processes of bone marrow cell proliferation and maturation.
Laboratoire d'Hématologie Expérimentale, Faculté de Médecine, Limoges, France.
Y
Y
Denizot
F
F
Trimoreau
F
F
Dupuis
C
C
Verger
V
V
Praloran
D043203:1-Alkyl-2-acetylglycerophosphocholine Esterase; D001853:Bone Marrow / Q000378:metabolism*; D006410:Hematopoiesis; D006801:Humans; D007958:Leukocyte Count; D010741:Phospholipases A / Q000378:metabolism; D010972:Platelet Activating Factor / Q000037:antagonists & inhibitors / Q000378:metabolism*
D010972:Platelet Activating Factor; D010741:Phospholipases A; D043203:1-Alkyl-2-acetylglycerophosphocholine Esterase